Moreau Mathieu
Known title: Sr. VP of Sales and ProductsCIK: 0001864396
Associated companies
Transaction History
| XPEL | ▲ Buy | Option Exercise | 912 | — | 9/7/2023 | View on chart |
| XPEL | ▼ Sell | Open Market | 5,000 | $414K | 8/25/2023 | View on chart |
| XPEL | ▼ Sell | Open Market | 5,000 | $424K | 8/24/2023 | View on chart |
| XPEL | ▼ Sell | Open Market | 5,000 | $424K | 8/23/2023 | View on chart |
| XPEL | ▼ Sell | Open Market | 5,000 | $416K | 8/22/2023 | View on chart |
| XPEL | ▼ Sell | Open Market | 5,000 | $415K | 8/21/2023 | View on chart |
| XPEL | ▼ Sell | Open Market | 5,000 | $413K | 8/18/2023 | View on chart |
| XPEL | ▼ Sell | Open Market | 5,000 | $415K | 8/17/2023 | View on chart |
| XPEL | ▼ Sell | Open Market | 5,000 | $420K | 8/16/2023 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 742 | — | 7/15/2023 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 742 | — | 7/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
XPEL’s $110M Expansion Sparks Undervaluation Debate
XPEL announced a $110 million expansion that has led some analysts to suggest the stock may be 29% undervalued. The move highlights the company’s focus on growth while maintaining a reasonable valuation. Analysts still see the stock as a GARP play with solid earnings and a target price around $61.67.
XPEL’s $110M Expansion Sparks Undervaluation Debate. XPEL announced a $110 million expansion that has led some analysts to suggest the stock may be 29% undervalued. The move highlights the company’s focus on growth while maintaining a reasonable valuation. Analysts still see the stock as a GARP play with solid earnings and a target price around $61.67.